GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » Days Sales Outstanding

Hunan Jiudian Pharmaceutical Co (SZSE:300705) Days Sales Outstanding : 44.76 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Hunan Jiudian Pharmaceutical Co Days Sales Outstanding?

Hunan Jiudian Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥341 Mil. Hunan Jiudian Pharmaceutical Co's Revenue for the three months ended in Mar. 2025 was ¥696 Mil. Hence, Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 44.76.

The historical rank and industry rank for Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300705' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.05   Med: 47.97   Max: 68.04
Current: 47.35

During the past 12 years, Hunan Jiudian Pharmaceutical Co's highest Days Sales Outstanding was 68.04. The lowest was 44.05. And the median was 47.97.

SZSE:300705's Days Sales Outstanding is ranked better than
76.7% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs SZSE:300705: 47.35

Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding declined from Mar. 2024 (75.54) to Mar. 2025 (44.76).


Hunan Jiudian Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jiudian Pharmaceutical Co Days Sales Outstanding Chart

Hunan Jiudian Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.05 46.32 55.47 68.04 55.80

Hunan Jiudian Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.54 50.76 49.95 45.02 44.76

Competitive Comparison of Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding falls into.


;
;

Hunan Jiudian Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (545.569 + 350.503) / 2 ) / 2930.677*365
=448.036 / 2930.677*365
=55.80

Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (350.503 + 332.261) / 2 ) / 696.028*365 / 4
=341.382 / 696.028*365 / 4
=44.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Jiudian Pharmaceutical Co  (SZSE:300705) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Hunan Jiudian Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hunan Jiudian Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Jiudian Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Health Avenue, Hunan Liuyang Bio Pharmaceutical Park, Hunan, Changsha, CHN, 410329
Hunan Jiudian Pharmaceutical Co Ltd is a China-based pharmaceutical company specializing in research and development, manufacturing of pharmaceutical products, solid and liquid oral preparations and herbal extract products. It manufactures dirithromycin, levodropropizine and levocetirizine hydrochloride in China. The group's products include active pharmaceutical ingredients, herbal extracts, intermediaries, excipients and finished products.
Executives
Xiong Ying Executives
Zhu Zhi Hong Director
Duan Bin Supervisors
Liang Sheng Hua Supervisors
Zheng Xia Hui Directors, executives
Duan Li Xin Director
Zhu Zhi Yun Director
Li Min Secretary Dong
Fan Peng Yun Executives

Hunan Jiudian Pharmaceutical Co Headlines

No Headlines